Skip to main content

Advertisement

Log in

Surgical Treatment of Mass-Forming Intrahepatic Cholangiocarcinoma: An 11-Year Western Single-Center Experience in 107 Patients

  • Hepatobiliary and Pancreatic Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Hepatic resection is the only cure for intrahepatic cholangiocellular carcinoma (ICC). The purpose of this study was to clarify the clinicopathologic characteristics and surgical outcome of patients with ICC. We retrospectively studied the records of 67 patients who underwent laparotomy for ICC from January 1995 through December 2005. Univariate and multivariate analyses were conducted for several variables to evaluate their influence on the outcome. Forty-five patients underwent hepatic resection. In 19 patients, the tumors were found to be unresectable at the time of laparotomy. Median 2- and 5-year survival rates in the 45 resected patients were 62% and 35%, respectively. For 36 patients who underwent curative resection, the 2- and 5-year survival were 67% and 41%, respectively; with a median survival of 43 months. The overall 5-year recurrence-free survival was 30%. The 90-day postoperative mortality rate was 4% and morbidity 28%. Multivariate analyses confirmed resection margin, lymph node involvement, blood loss, and blood transfusion to be independent significant variables for overall survival. Predictors of longer recurrence-free survival were lymph node involvement, vascular infiltration, blood loss, and transfusion. Surgical treatment of ICC by curative hepatic resection in patients without nodal invasion provides good long-term results. In contrast, incomplete tumor removal does not provide a survival benefit. An improved quality of preoperative staging was able to increase the resectability rate to acceptable 70%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Vatanasapt V, Uttaravichien T, Mairiang EO, et al. Cholangiocarcinoma in north-east Thailand. Lancet. 1990; 335:11617.

    Article  Google Scholar 

  2. Chen MF, Jan YY, Wang CS, et al. Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma. Cancer. 1989;64:2226–32.

    Article  PubMed  CAS  Google Scholar 

  3. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33:1353–7.

    Article  PubMed  CAS  Google Scholar 

  4. Shaib Y, El-Sareg HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24:115–25.

    Article  PubMed  Google Scholar 

  5. Shaib Y, Davila JA, McGlynn K, et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004;40:472–7.

    Article  PubMed  Google Scholar 

  6. Taylor-Robinson SD, Toledano MB, Arora S, et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998. Gut. 2001;48:816–20.

    Article  PubMed  CAS  Google Scholar 

  7. Endo I, Gonen M, Yopp Ac, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248:84–96.

    Article  PubMed  Google Scholar 

  8. Roayaie S, Guarrera JV, Ye MQ, et al. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg. 1998;187:365–72.

    Article  PubMed  CAS  Google Scholar 

  9. Lang H, Sotiropoulos GC, Frühauf NR, et al. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg. 2005;241:134–43.

    PubMed  Google Scholar 

  10. Kawarada Y, Yamagiwa K, Das BC. Analysis of the relationship between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg. 2002;183:679–85.

    Article  PubMed  Google Scholar 

  11. Suzuki S, Sakaguchi T, Yokoi Y, et al. Clinicopathologic prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg. 2002;26:687–93.

    Article  PubMed  Google Scholar 

  12. Konstadoulakis MM, Roayaie S, Gomatos IP, et al. Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery. 2008;143:366–74.

    Article  PubMed  Google Scholar 

  13. Puhalla H, Schuell B, Pokorny H, et al. Treatment and outcome of intrahepatic cholangiocellular carcinoma. Am J Surg. 2005;189:173–7.

    Article  PubMed  Google Scholar 

  14. Madariaga JR, Iwatsuki S, Todo S, et al. Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg. 1998;227:70–9.

    Article  PubMed  CAS  Google Scholar 

  15. Yamamoto J, Kosuge T, Takayama T, et al. Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years. Surgery. 1992;111:617–22.

    PubMed  CAS  Google Scholar 

  16. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224:463–75.

    Article  PubMed  CAS  Google Scholar 

  17. Sobin SH, Wittekind C. TNM—Classification of Malignant Tumors. New York: Wiley-Liss; 1997.

    Google Scholar 

  18. Khan SA, Taylor-Robinson SD, Toledano MB, et al. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 2002;37:806–13.

    Article  PubMed  Google Scholar 

  19. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002;2:10.

    Article  PubMed  Google Scholar 

  20. Khan SA, Thomas HC, Davidson BR, et al. Cholangiocarcinoma. Lancet. 2005;366:1303–14.

    Article  PubMed  Google Scholar 

  21. Harrison LE, Fong Y, Klimstra DS, et al. Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Br J Surg. 1998;85:1068–70.

    Article  PubMed  CAS  Google Scholar 

  22. Washburn WK, Lewis WD, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg. 1995;130:270–6.

    PubMed  CAS  Google Scholar 

  23. Weimann A, Varnholt H, Schlitt HJ, et al. Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma. Br J Surg. 2000;87:1182–7.

    Article  PubMed  CAS  Google Scholar 

  24. Casavilla FA, Marsh JW, Iwatsuki S, et al. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg. 1997;185:429–36.

    PubMed  CAS  Google Scholar 

  25. Weber SM, Jarnagin WR, Klimstra D, et al. Intrahepatic cholangiocarcinoma: respectability, recurrence pattern, and outcomes. J Am Coll Surg. 2001;193:384–91.

    Article  PubMed  CAS  Google Scholar 

  26. Suh KS, Chang SH, Lee HJ, et al. Clinical outcomes and apomucin expression of intrahepatic cholangiocarcinoma according to gross morphology. J Am Coll Surg. 2002;195:782–9.

    Article  PubMed  Google Scholar 

  27. Isa T, Kusano T, Shimoji H, et al. Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg. 2001;181:507–11.

    Article  PubMed  CAS  Google Scholar 

  28. Uenishi T, Hirohashi K, Kubo S, et al. Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg. 2001;88:969–74.

    Article  PubMed  CAS  Google Scholar 

  29. Hirohashi K, Uenishi T, Kubo S, et al. Macroscopic types of intrahepatic cholangiocarcinoma: clinicipathologic features and surgical outcomes. Hepatogastroenterology. 2002;49:326–9.

    PubMed  Google Scholar 

  30. Anderson CD, Pinson CW, Berlin J, et al. Diagnosis and treatment of cholangiocarcinoma. Oncologist. 2004;9:43–57.

    Article  PubMed  Google Scholar 

  31. Nakeeb A, Tran KQ, Black MJ, et al. Improved survival in resected biliary malignancies. Surgery. 2002;132:555–63.

    Article  PubMed  Google Scholar 

  32. Schlinkert RT, Nagorney DM, Van Heerden JA, et al. Intrahepatic cholangiocarcinoma: clinical aspects, pathology and treatment. HPB Surg. 1992;5:95–101.

    Article  PubMed  CAS  Google Scholar 

  33. Berdah SV, Delpero JR, Garcia S, et al. A Western surgical experience of peripheral cholangiocarcinoma. Br J Surg. 1996;83:1517–21.

    Article  PubMed  CAS  Google Scholar 

  34. Jan YY, Jeng LB, Hwang TL, et al. Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma. Hepatogastroenterology. 1996;43:614–9.

    PubMed  CAS  Google Scholar 

  35. Pichlmayr R, Lamesch P, Weimann A, et al. Surgical treatment of cholangiocellular carcinoma. World J Surg. 1995;19:83–8.

    Article  PubMed  CAS  Google Scholar 

  36. Lieser MJ, Barry MK, Rowland C, et al. Surgical management of intrahepatic cholangiocarcinoma: a 31-year experience. J Hepatobiliary Pancreat Surg. 1998;5:41–7.

    Article  PubMed  CAS  Google Scholar 

  37. Yamanaka N, Okamoto E, Ando T, et al. Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma. Cancer. 1995;76:2449–56.

    Article  PubMed  CAS  Google Scholar 

  38. Nagakawa T, Kamiyama T, Kurauchi N, et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg. 2005;29:728–33.

    Article  Google Scholar 

  39. Ohtsuka M, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg. 2002;89:1525–31.

    Article  PubMed  CAS  Google Scholar 

  40. Shimada M, Yamashita Y, Aishima S, et al. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg. 2001;88:1463–6.

    Article  PubMed  CAS  Google Scholar 

  41. Inoue K, Makuuchi M, Takayama T, et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery. 2000;127:498–505.

    Article  PubMed  CAS  Google Scholar 

  42. Chu KM, Lai EC, Al-Hadeedi S, et al. Intrahepatic cholangiocarcinoma. World J Surg. 1997;21:301–5.

    Article  PubMed  CAS  Google Scholar 

  43. Shirabe K, Shimada M, Harimoto N, et al. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery. 2002;131:S159–64.

    Article  PubMed  Google Scholar 

  44. Valverde A, Bonhomme N, Farges O, et al. Resection of intrahepatic cholangiocarcinoma: a Western experience. J Hepatobiliary Pancreat Surg. 1999;6:122–7.

    Article  PubMed  CAS  Google Scholar 

  45. Itamoto T, Asahara T, Katayama K, et al. Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology. Hepatogastroenterology. 2001;48:1129–33.

    PubMed  CAS  Google Scholar 

  46. Grobmyer SR, Wang L, Gonen M, et al. Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy. Ann Surg. 2006;244:260–4.

    Article  PubMed  Google Scholar 

  47. Sasaki A, Aramaki M, Kawano K, et al. Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg. 1998;85:1206–9.

    Article  PubMed  CAS  Google Scholar 

  48. Shimada K, Sano T, Sakamoto Y, et al. Surgical outcomes of mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg. 2007;31:2016–22.

    Article  PubMed  Google Scholar 

  49. Miwa S, Miyagawa S, Kobayashi A, et al. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the following surgery. J Gastroenterol. 2006;41:893–900.

    Article  PubMed  CAS  Google Scholar 

  50. Scheele J, Altendorf-Hofmann A, Grube T, et al. Resection of colorectal liver metastases: which prognostic factors should govern patient selection? Chirurg. 2001;72:547–60.

    Article  PubMed  CAS  Google Scholar 

  51. Yedibela S, Gohl J, Graz V, et al. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol. 2005;12:778–85.

    Article  PubMed  Google Scholar 

  52. Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698–708.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Süleyman Yedibela PD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yedibela, S., Demir, R., Zhang, W. et al. Surgical Treatment of Mass-Forming Intrahepatic Cholangiocarcinoma: An 11-Year Western Single-Center Experience in 107 Patients. Ann Surg Oncol 16, 404–412 (2009). https://doi.org/10.1245/s10434-008-0227-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-008-0227-1

Keywords

Navigation